The International Society of Pharmaceutical Engineering (ISPE) has announced the winners of its 2025 Facility of the Year Awards (FOYA) at the ISPE Europe Annual Conference in London. This year's announcement holds special significance as it marks the 20th anniversary of the prestigious program that recognizes excellence and innovation in pharmaceutical manufacturing facilities.
Six category winners and two honorable mentions were selected from a competitive pool of finalists, showcasing advancements across innovation, operations, Pharma 4.0™, and social impact categories.
"The 2025 FOYA category winners exemplify innovation and excellence that continues to elevate the pharmaceutical industry," said Parag Sane, AVP, Global Capital Projects at Amgen and 2025 FOYA Judging Chair. "Their forward-thinking projects not only advance manufacturing standards and champion sustainability but also reflect a commitment to improving human lives around the world."
Innovation Category Winner
Touchlight received the Innovation category award for its project "Development and Manufacture of Novel Synthetic DNA to Enable the Future of Genetic Medicines" located in Hampton, London, UK. The facility represents a significant advancement in genetic medicine manufacturing capabilities.
Operations Excellence Winners
Johnson & Johnson Innovative Medicine secured two operations category awards. Their "Flexible Bottle Packaging Line" in Latina, Italy won the Operations Excellence award, while their "BioCork 3.2 Expansion Project" in Ringaskiddy, Cork, Ireland was recognized for Project Execution excellence.
Pharma 4.0™ Leadership
CSL Behring's "Project Aurora – Facility F Base Fractionation" in Broadmeadows, Victoria, Australia was honored with the Pharma 4.0™ category award, highlighting the integration of advanced digital technologies in pharmaceutical manufacturing.
Social Impact Recognition
The Social Impact category featured two winners. Bayer Healthcare LLC received recognition for addressing unmet medical needs with their "Cell Therapy Launch and Manufacturing Facility" in Berkeley, California. Sanofi won the Sustainability Excellence award for their "Building 99 – Wastewater Treatment and Recovery Plant" in Toronto, Ontario, Canada.
Honorable Mentions
Two facilities received honorable mentions: Erbe Elektromedizin GmbH's "Erbe 4.i" project in Rangendingen, Germany, and United Therapeutics' "Clinical Xenotransplantation DPF Facility" in Christiansburg, Virginia, USA.
"Innovation propels our industry forward. ISPE is committed to continuing to champion new ideas that are helping to shape the future of the industry," said Mike Martin, President and CEO of ISPE. "As the ISPE FOYA program celebrates its 20th anniversary year, we look forward to coming together for the 2025 FOYA Banquet and Awards Celebration to honor this year's highly accomplished category winners."
Anniversary Celebration
The overall 2025 FOYA winner will be announced at a special black-tie celebration during the 2025 ISPE Annual Meeting & Expo in Charlotte, North Carolina, USA, scheduled for October 26-29, 2025. The 20th-anniversary event will feature speeches from award recipients, keynote sessions from industry leaders, and networking opportunities with manufacturing and engineering experts.
Established in 2005, the FOYA program recognizes state-of-the-art pharmaceutical facilities that utilize innovative technologies to improve product quality, reduce production costs, and demonstrate advances in project delivery. The program provides a platform for the pharmaceutical industry to showcase accomplishments in facility design, construction, and operation.
The International Society for Pharmaceutical Engineering serves over 22,000 members globally through scientific, technical, and regulatory advancement across the entire pharmaceutical lifecycle. With headquarters in North Bethesda, Maryland, and operations center in Tampa, Florida, ISPE continues to drive excellence and innovation in pharmaceutical manufacturing worldwide.
